Skip to content

REVATIS VET

Active Private limited companyfounded 2024active for 2 yearsAye, Rue de la Science 8, 6900 Marche-en-FamenneKBO/BCE: BE 1015.868.627

Lifetime

1 annual account with figures
peak of €3,210 in 2025
€3,210 
lowest -€112,410 in 2025
-€112,410 
peak of €483,081 in 2025
€483,081 
€131,777 
Board4 names since 2024
2 directors and 1 other
Documentsfilings and deeds
21-07-202610 days before the deadline
2025micro format
Loss of €112,410First year with figures

Key points

from the 2025 annual accounts

Turnover

≈ €38,000 estimated

The micro format states no turnover.

Position in the sector

-€112,410

Lower net result than 95% of companies in wholesale trade. Sector median €5,116 · 15,498 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 132 companies had the same profile as REVATIS VET has now. Each dot is one company, two years later.

93.2%
were still trading
3.8%
stopped another way
3.0%
went bankrupt
  • Small
  • 2 to 5 years old
  • solvency 30% or more
  • a loss of 10% of the balance sheet or more
Test of the method

The method was tested on the 497,965 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 132 companies, not a prediction for REVATIS VET. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 04-11-2024
Director, , since 04-11-2024
  • 2,000 sharesdeed of 06-11-2024
  • 1,600 sharesdeed of 06-11-2024
  • 1,200 sharesdeed of 06-11-2024
and 1 other shareholderBoard & ownership

Recent changes

resigns as director acts as permanent representative · Gazette deed
Registered in the Peppol Directory Reachable for e-invoices through 0208:1015868627
Transfer: REVATIS transfers a branch of activity to REVATIS VET (director) and (director) appointed · General meeting of 20-12-2024 · Gazette deed
Transfer proposal: RevaTis transfers a branch of activity to REVATIS VET Gazette deed
All 7 events

Comparable companies

same main activity, similar in size and age
Company
REVATIS VET Marche-en-Famenne €0.6m €3,210 78.6% -
LHP HEALTHCARE Seraing €0.5m -€31,029 97.2% -
Immunexpress Belgium Leuven €0.3m -€219,454 -93.5% -
ALICE Pajottegem €0.3m -€6,464 38.2% -
Amophar OTC Schelle €0.3m €4,288 5.5% 0
Taikun Pharmaceutical Technology Ghent €0.3m -€158,581 50.4% -
BRUCO MEDICAL Wommelgem €1.2m -€75,513 -30.4% 1.5

These companies have the same main activity as REVATIS VET: wholesale of pharmaceutical and medical goods (NACE 46460). They are comparable in size and age: total assets between €273,000 and €1.2m, founded between 2022 and 2025.

Official details

Source: KBO
Status
Active since 04-11-2024Normal situation
Registered office
22 active companies are registered at this address2 started in the 12 months before. Source: KBO register, as of 19 November 2026.
Activity
Wholesale of pharmaceutical and medical goodsNACE 46460
Establishment unit
2.367.207.3016900 Marche-en-Famenne, since 04-11-2024
Financial year end
31 December
Peppol
Reachable since 04-11-2025
Company details

Annual accounts 2025

€614,858
Filing
Filed on 21-07-2026, 10 days before the end of the filing period
Financials

Insights on REVATIS VET

REVATIS VET has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €483,081 and a net result of -€112,410.

Its solvency ranks better than 81% of 15,500 sector peers (NACE 46) in financial year 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about REVATIS VET

What is the company number of REVATIS VET?
The company number of REVATIS VET is 1015.868.627. The VAT number is the same number with BE in front: BE 1015.868.627.
Where is REVATIS VET based?
The registered office is at Aye, Rue de la Science 8, 6900 Marche-en-Famenne.Company details
What does REVATIS VET do?
According to the KBO register, the main activity is wholesale of pharmaceutical and medical goods (NACE 46460).
What is the legal form of REVATIS VET?
REVATIS VET is a private limited company (BV).
When was REVATIS VET founded?
REVATIS VET was founded on 04-11-2024.
Is REVATIS VET still active?
Yes, REVATIS VET is an active enterprise in the KBO register.
What is the turnover of REVATIS VET?
The turnover in financial year 2025 is ≈ €38,000. This figure is estimated from the gross margin of €3,210 and 53 comparable companies (NACE 464). It probably lies between €19,000 and €110,000. It is a rough estimate.Financials
Is REVATIS VET profitable?
In financial year 2025, REVATIS VET made a loss of €112,410.
Where can I find the annual accounts of REVATIS VET?
REVATIS VET filed 1 annual account with the National Bank of Belgium, for financial year 2025.

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.